Literature DB >> 32242892

Interaction of the neutral amino acid transporter ASCT2 with basic amino acids.

Elias Ndaru1, Rachel-Ann A Garibsingh2, Laura Zielewicz1, Avner Schlessinger2, Christof Grewer1.   

Abstract

Glutamine transport across cell membranes is performed by a variety of transporters, including the alanine serine cysteine transporter 2 (ASCT2). The substrate-binding site of ASCT2 was proposed to be specific for small amino acids with neutral side chains, excluding basic substrates such as lysine. A series of competitive inhibitors of ASCT2 with low µM affinity were developed previously, on the basis of the 2,4-diaminobutyric acid (DAB) scaffold with a potential positive charge in the side chain. Therefore, we tested whether basic amino acids with side chains shorter than lysine can interact with the ASCT2 binding site. Molecular docking of L-1,3-diaminopropionic acid (L-DAP) and L-DAB suggested that these compounds bind to ASCT2. Consistent with this prediction, L-DAP and L-DAB, but not ornithine, lysine or D-DAP, elicited currents when applied to ASCT2-expressing cells. The currents were carried by anions and showed the hallmark properties of ASCT2 currents induced by transported substrates. The L-DAP response could be eliminated by a competitive ASCT2 inhibitor, suggesting that binding occurs at the substrate binding site. The KM for L-DAP was weakly voltage dependent. Furthermore, the pH dependence of the L-DAP response showed that the compound can bind in several protonation states. Together, these results suggest that the ASCT2 binding site is able to recognize L-amino acids with short, basic side chains, such as the L-DAP derivative β-N-methylamino-l-Alanine (BMAA), a well-studied neurotoxin. Our results expand the substrate specificity of ASCT2 to include amino acid substrates with positively charged side chains.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  ASCT2; docking; electrophysiology; kinetics; neutral amino acid transporter; substrate selectivity

Mesh:

Substances:

Year:  2020        PMID: 32242892      PMCID: PMC9535927          DOI: 10.1042/BCJ20190859

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.766


  55 in total

1.  Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation.

Authors:  Mako Nakaya; Yichuan Xiao; Xiaofei Zhou; Jae-Hoon Chang; Mikyoung Chang; Xuhong Cheng; Marzenna Blonska; Xin Lin; Shao-Cong Sun
Journal:  Immunity       Date:  2014-05-01       Impact factor: 31.745

2.  Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family.

Authors:  J L Arriza; M P Kavanaugh; W A Fairman; Y N Wu; G H Murdoch; R A North; S G Amara
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

3.  Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.

Authors:  Masashi Namikawa; Satoru Kakizaki; Kyoichi Kaira; Hiroki Tojima; Yuichi Yamazaki; Norio Horiguchi; Ken Sato; Noboru Oriuchi; Hideyuki Tominaga; Yutaka Sunose; Shushi Nagamori; Yoshikatsu Kanai; Tetsunari Oyama; Izumi Takeyoshi; Masanobu Yamada
Journal:  Hepatol Res       Date:  2014-12-11       Impact factor: 4.288

4.  Potential transfer of neurotoxic amino acid β-N-methylamino-alanine (BMAA) from mother to infant during breast-feeding: Predictions from human cell lines.

Authors:  Marie Andersson; Lisa Ersson; Ingvar Brandt; Ulrika Bergström
Journal:  Toxicol Appl Pharmacol       Date:  2017-02-04       Impact factor: 4.219

Review 5.  The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects.

Authors:  Yoshikatsu Kanai; Matthias A Hediger
Journal:  Pflugers Arch       Date:  2003-10-07       Impact factor: 3.657

6.  The l-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier.

Authors:  Kazuhiro Tetsuka; Hitomi Takanaga; Sumio Ohtsuki; Ken-ichi Hosoya; Tetsuya Terasaki
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

7.  Visualization of glutamine transporter activities in living cells using genetically encoded glutamine sensors.

Authors:  Katrin Gruenwald; John Todd Holland; Verlyn Stromberg; Altaf Ahmad; Daisy Watcharakichkorn; Sakiko Okumoto
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

8.  ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.

Authors:  K Shimizu; K Kaira; Y Tomizawa; N Sunaga; O Kawashima; N Oriuchi; H Tominaga; S Nagamori; Y Kanai; M Yamada; T Oyama; I Takeyoshi
Journal:  Br J Cancer       Date:  2014-03-06       Impact factor: 7.640

Review 9.  Amino acid homeostasis and signalling in mammalian cells and organisms.

Authors:  Stefan Bröer; Angelika Bröer
Journal:  Biochem J       Date:  2017-05-25       Impact factor: 3.857

10.  Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds.

Authors:  Elias Ndaru; Rachel-Ann A Garibsingh; YueYue Shi; Evan Wallace; Paul Zakrepine; Jiali Wang; Avner Schlessinger; Christof Grewer
Journal:  J Gen Physiol       Date:  2019-02-04       Impact factor: 4.086

View more
  2 in total

1.  Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis.

Authors:  Dunlop Ra; Banack Sa; Bishop Sl; Metcalf Js; Murch Sj; Davis DA; Stommel Ew; Karlsson O; Brittebo Eb; Chatziefthimiou Ad; Tan Vx; Guillemin Gg; Cox Pa; Mash Dc; Bradley Wg
Journal:  Neurotox Res       Date:  2021-02-06       Impact factor: 3.911

2.  The Human SLC1A5 Neutral Amino Acid Transporter Catalyzes a pH-Dependent Glutamate/Glutamine Antiport, as Well.

Authors:  Mariafrancesca Scalise; Tiziano Mazza; Gilda Pappacoda; Lorena Pochini; Jessica Cosco; Filomena Rovella; Cesare Indiveri
Journal:  Front Cell Dev Biol       Date:  2020-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.